Skip to main content

Glycoconjugates and Neuroimmunological Diseases

  • Chapter
  • First Online:
Glycobiology of the Nervous System

Part of the book series: Advances in Neurobiology ((NEUROBIOL,volume 9))

Abstract

A wide range of neuroimmunological diseases affect the central and peripheral nervous systems. These disorders are caused by autoimmune attack directed against structurally and functionally diverse nervous system antigens. One such category comprises peripheral nervous system (PNS) diseases, termed peripheral neuropathies, in which the target antigens for autoantibody-directed nerve injury are glycan structures borne by glycoproteins and glycolipids, particularly gangliosides that are concentrated in peripheral nerve. The archetypal PNS disorder is the acute paralytic disease, Guillain–Barré syndrome (GBS) in which autoantibodies against glycolipids arise in the context of acute infections that precede the clinical onset, notably Campylobacter jejuni enteritis. In addition, several chronic autoimmune neuropathies are associated with IgM antibodies directed against nerve glycans including sulphated glucuronic acid epitopes present on myelin-associated glycoprotein and sulphated glucuronyl paragloboside, a range of disialylated gangliosides including GD1b and GD3, and GM1 ganglioside. This chapter describes the immunological, pathological and clinical features of these disorders in the context of our broader knowledge of the glycobiology underpinning this neuroimmunological field.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bullens RW, O’Hanlon GM, Wagner E, Molenaar PC, Furukawa K, Furukawa K, Plomp JJ, Willison HJ. Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci. 2002;22:6876–84.

    CAS  PubMed  Google Scholar 

  • Burger D, Simon M, Peruisseau G, Steck AJ. The epitope(s) recognised by HNK-1 antibody and IgM paraprotein in neuropathy is present on several N-linked oligosaccharide structures on human P0 and myelin-associated glycoprotein. J Neurochem. 1990;54:1569–75.

    Article  CAS  PubMed  Google Scholar 

  • Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology. 1993;43:1911–7.

    Article  CAS  PubMed  Google Scholar 

  • Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997;745:32–6.

    Article  CAS  PubMed  Google Scholar 

  • Defrance T, Taillardet M, Genestier L. T cell-independent B cell memory. Curr Opin Immunol. 2011;23:330–6.

    Article  CAS  PubMed  Google Scholar 

  • Fewou SN, Rupp A, Nickolay LE, Carrick K, Greenshields KN, Pediani J, Plomp JJ, Willison HJ. Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. J Clin Invest. 2012;122:1037–51.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Galban-Horcajo F, Fitzpatrick AM, Hutton AJ, Dunn SM, Kalna G, Brennan KM, Rinaldi S, Yu RK, Goodyear CS, Willison HJ. Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy. Eur J Neurol. 2012;20:62–70.

    Article  PubMed  Google Scholar 

  • Gillingwater TH, Ribchester RR. The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice. J Neurocytol. 2003;32:863–81.

    Article  CAS  PubMed  Google Scholar 

  • Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, Humphreys PD, Wagner ER, Yuki N, Furukawa K, Furukawa K, Plomp JJ, Willison HJ. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci. 2005;25:1620–8.

    Article  CAS  PubMed  Google Scholar 

  • Greenshields KN, Halstead SK, Zitman FM, Rinaldi S, Brennan KM, O’Leary C, Chamberlain LH, Easton A, Roxburgh J, Pediani J, Furukawa K, Furukawa K, Goodyear CS, Plomp JJ, Willison HJ. The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J Clin Invest. 2009;119:595–610.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gu Y, Chen ZW, Siegel A, Koshy R, Ramirez C, Raabe TD, Devries GH, Ilyas AA. Analysis of humoral immune responses to LM1 ganglioside in guinea pigs. J Neuroimmunol. 2012;246:58–64.

    Article  CAS  PubMed  Google Scholar 

  • Hafer-Macko C, Hsieh ST, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM, Asbury AK, Griffin JW. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 1996a;40:635–44.

    Article  CAS  PubMed  Google Scholar 

  • Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol. 1996b;39:625–35.

    Article  CAS  PubMed  Google Scholar 

  • Halstead SK, Morrison I, O’Hanlon GM, Humphreys PD, Goodfellow JA, Plomp JJ, Willison HJ. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia. 2005;52:177–89.

    Article  PubMed  Google Scholar 

  • Halstead SK, Zitman FM, Humphreys PD, Greenshields K, Verschuuren JJ, Jacobs BC, Rother RP, Plomp JJ, Willison HJ. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain. 2008;131:1197–208.

    Article  PubMed  Google Scholar 

  • Hays AP, Latov N, Takatsu M, Sherman WH. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti MAG IgM M protein. Neurology. 1987;37:242–56.

    Article  CAS  PubMed  Google Scholar 

  • Hitoshi S, Kusunoki S, Murayama S, Tsuji S, Kanazawa I. Rabbit experimental sensory ataxic neuropathy: anti-GD1b antibody-mediated trkC downregulation of dorsal root ganglia neurons. Neurosci Lett. 1999;260:157–60.

    Article  CAS  PubMed  Google Scholar 

  • Ho TW, Hsieh ST, Nachamkin I, Willison HJ, Sheikh K, Kiehlbauch J, Flanigan K, McArthur JC, Cornblath DR, McKhann GM, Griffin JW. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology. 1997;48:717–24.

    Article  CAS  PubMed  Google Scholar 

  • Honke K. Biosynthesis and biological function of sulfoglycolipids. Proc Jpn Acad Ser B Phys Biol Sci. 2013;89:129–38.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Houliston RS, Jacobs BC, Tio-Gillen AP, Verschuuren JJ, Khieu NH, Gilbert M, Jarrell HC. STD-NMR used to elucidate the fine binding specificity of pathogenic anti-ganglioside antibodies directly in patient serum. Biochemistry. 2009;48:220–2.

    Article  CAS  PubMed  Google Scholar 

  • Houliston RS, Koga M, Li J, Jarrell HC, Richards JC, Vitiazeva V, Schweda EK, Yuki N, Gilbert M. A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry. 2007;46:8164–71.

    Article  CAS  PubMed  Google Scholar 

  • Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet. 2005;366:1653–66.

    Article  CAS  PubMed  Google Scholar 

  • Ilyas AA, Dalakas MC, Brady RO, Quarles RH. Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes. Brain Res. 1986;385:1–9.

    Article  CAS  PubMed  Google Scholar 

  • Inoue M, Fujii Y, Furukawa K, Okada M, Okumura K, Hayakawa T, Furukawa K, Sugiura Y. Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside. J Biol Chem. 2002;277:29881–8.

    Article  CAS  PubMed  Google Scholar 

  • Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S. Ganglioside complexes as new target antigens in Guillain-Barre syndrome. Ann Neurol. 2004;56:567–71.

    Article  CAS  PubMed  Google Scholar 

  • Kanda T. Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies. J Neurol Neurosurg Psychiatry. 2013;84:208–12.

    Article  PubMed  Google Scholar 

  • Kieseier BC, Hartung HP, Wiendl H. Immune circuitry in the peripheral nervous system. Curr Opin Neurol. 2006;19:437–45.

    Article  CAS  PubMed  Google Scholar 

  • Kornberg AJ, Pestronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. Ann Neurol. 1995;37:S43–50.

    Article  PubMed  Google Scholar 

  • Kusunoki S. Anti-ganglioside antibodies in Guillain-Barre syndrome; useful diagnostic markers as well as possible pathogenetic factors. Intern Med. 2003;42:457–8.

    Article  PubMed  Google Scholar 

  • Kusunoki S, Hitoshi S, Kaida K, Arita M, Kanazawa I. Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy. Ann Neurol. 1999;45:400–3.

    Article  CAS  PubMed  Google Scholar 

  • Kusunoki S, Shimizu J, Chiba R, Ugawa Y, Hitoshi S, Kanazawa I. Experimental sensory neuropathy induced by sensitisation with ganglioside GD1b. Ann Neurol. 1996;39:324–31.

    Google Scholar 

  • Ledeen RW, Yu RK. Gangliosides: structure, isolation, and analysis. Methods Enzymol. 1982;83:139–91.

    Article  CAS  PubMed  Google Scholar 

  • Lloyd KO, Gordon CM, Thampoe IJ, DiBenedetto C. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells. Cancer Res. 1992;52:4948–53.

    CAS  PubMed  Google Scholar 

  • Lopate G, Parks BJ, Goldstein JM, Yee WC, Friesenhahn GM, Pestronk A. Polyneuropathies associated with high titre antisulphatide antibodies: characteristics of patients with and without serum monoclonal proteins. J Neurol Neurosurg Psychiatry. 1997;62:581–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Martin PT. Glycobiology of the neuromuscular junction. J Neurocytol. 2003;32:915–29.

    Article  CAS  PubMed  Google Scholar 

  • McGonigal R, Rowan EG, Greenshields KN, Halstead SK, Humphreys PD, Rother RP, Furukawa K, Willison HJ. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain. 2010;133:1944–60.

    Article  PubMed  Google Scholar 

  • Meyer Zu HG, Hu W, Hartung HP, Lehmann HC, Kieseier BC. The immunocompetence of Schwann cells. Muscle Nerve. 2008;37:3–13.

    Article  Google Scholar 

  • Mori L, De LG. T cells specific for lipid antigens. Immunol Res. 2012;53:191–9.

    Article  CAS  PubMed  Google Scholar 

  • Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, Bonetti B, Cavaletti G, Gemignani F, Durelli L, Barbieri S, Allaria S, Sgarzi M, Scarlato G. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol. 1994;36:416–24.

    Article  CAS  PubMed  Google Scholar 

  • O’Hanlon GM, Humphreys PD, Goldman RS, Halstead SK, Bullens RW, Plomp JJ, Ushkaryov Y, Willison HJ. Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain. 2003;126:2497–509.

    Article  PubMed  Google Scholar 

  • Ogawa-Goto K, Funamoto N, Ohta Y, Abe T, Nagashima K. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J Neurochem. 1992;59:1844–9.

    Article  CAS  PubMed  Google Scholar 

  • Plomp JJ, Willison HJ. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol. 2009;587:3979–99.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Popko B, Dupree JL, Coetzee T, Suzuki K, Suzuki K. Genetic analysis of myelin galactolipid function. Adv Exp Med Biol. 1999;468:237–44.

    Article  CAS  PubMed  Google Scholar 

  • Regina TA, Hakomori SI. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta. 2008;1780:421–33.

    Article  Google Scholar 

  • Rinaldi S, Brennan KM, Goodyear CS, O’Leary C, Schiavo G, Crocker PR, Willison HJ. Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology. 2009;19:789–96.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rinaldi S, Brennan KM, Willison HJ. Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding. Prog Lipid Res. 2010;49:87–95.

    Article  CAS  PubMed  Google Scholar 

  • Rinaldi S, Willison HJ. Ganglioside antibodies and neuropathies. Curr Opin Neurol. 2008;21:540–6.

    Article  CAS  PubMed  Google Scholar 

  • Saida T, Saida K, Dorfman SH, Silberberg DH, Sumner AJ, Manning MC, Lisak RP, Brown MJ. Experimental allergic neuritis induced by sensitization with galactocerebroside. Science. 1979;204:1103–6.

    Article  CAS  PubMed  Google Scholar 

  • Salzer JL, Brophy PJ, Peles E. Molecular domains of myelinated axons in the peripheral nervous system. Glia. 2008;56:1532–40.

    Article  PubMed  Google Scholar 

  • Sandhoff K, Kolter T. Biosynthesis and degradation of mammalian glycosphingolipids. Philos Trans R Soc Lond B Biol Sci. 2003;358:847–61.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Scherer SS. Molecular genetics of demyelination: new wrinkles on an old membrane. Neuron. 1997;18:13–6.

    Article  CAS  PubMed  Google Scholar 

  • Schwarz A, Futerman AH. The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies. Biochim Biophys Acta. 1996;1286:247–67.

    Article  CAS  PubMed  Google Scholar 

  • Sumner A. Electrophysiological and morphological effects of the injection of Guillain-BarrĂ© sera in the sciatic nerve of the rat. Rev Neurol (Paris). 1982;138:17–24.

    CAS  Google Scholar 

  • Susuki K, Nishimoto Y, Yamada M, Baba M, Ueda S, Hirata K, Yuki N. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol. 2003;54:383–8.

    Article  PubMed  Google Scholar 

  • Svennerholm L, Bostrom K, Fredman P, Jungbjer B, Lekman A, Mansson JE, Rynmark BM. Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. Biochim Biophys Acta. 1994;1214:115–23.

    Article  CAS  PubMed  Google Scholar 

  • Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol. 1993;33:502–6.

    Article  CAS  PubMed  Google Scholar 

  • Todeschini AR, Dos Santos JN, Handa K, Hakomori SI. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc Natl Acad Sci U S A. 2008;105:1925–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Varki A. Selectin ligands. Proc Natl Acad Sci USA. 1994;91:7390–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Willison HJ, Goodyear CS. Glycolipid antigens and autoantibodies in autoimmune neuropathies. Trends Immunol. 2013;34:453–9.

    Article  CAS  PubMed  Google Scholar 

  • Willison HJ, Halstead SK, Beveridge E, Zitman FM, Greenshields KN, Morgan BP, Plomp JJ. The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barre syndrome. J Neuroimmunol. 2008;201–202:172–82.

    Article  PubMed  Google Scholar 

  • Willison HJ, O’Leary CP, Veitch J, Blumhardt LD, Busby M, Donaghy M, Fuhr P, Ford H, Hahn A, Renaud S, Katifi HA, Ponsford S, Reuber M, Steck A, Sutton I, Schady W, Thomas PK, Thompson AJ, Vallat JM, Winer J. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain. 2001;124:1968–77.

    Article  CAS  PubMed  Google Scholar 

  • Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 2002;125:2591–625.

    Article  PubMed  Google Scholar 

  • Yinchang Y, Crawford TO, Griffin JW, Tu P, Lee VMY, Li C, Roder J, Trapp BD. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci. 1998;18:1953–62.

    Google Scholar 

  • Yu RK, Ariga T, Kohriyama T, Kusunoki S, Maeda Y, Miyatani N. Autoimmune mechanisms in peripheral neuropathies. Ann Neurol. 1990;27:S30–5.

    Article  CAS  PubMed  Google Scholar 

  • Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect Dis. 2001;1:29–37.

    Article  CAS  PubMed  Google Scholar 

  • Yuki N. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barre syndrome. J Neurochem. 2007;103:S150–8.

    Article  Google Scholar 

  • Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K. Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol. 2001;49:712–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of Interest 

The author declares no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hugh J. Willison .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Willison, H.J. (2014). Glycoconjugates and Neuroimmunological Diseases. In: Yu, R., Schengrund, CL. (eds) Glycobiology of the Nervous System. Advances in Neurobiology, vol 9. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1154-7_25

Download citation

Publish with us

Policies and ethics